What is high -quality intraepithelial neoplasia of prostate?
High quality prostate intraepithelial neoplasia is a precancer cell change found in the prostate gland. It can be a predictor for future prostate cancer, suggesting that the patient must visit regular monitoring to monitor the gland so that it can signs of cellular changes. Early cancer identification can help with rapid treatment that can improve the patient's results; However, some patients may receive unnecessarily invasive testing and treatment for slow -moving cellular changes that could be unlikely to be fatal than the patient dies of a unrelated problem. It can be performed through the rectum using the aspiration procedure of the needle or surgically, in which case the surgeon takes part of the gland. The pathologist examines the sample to determine whether it has signs of changes that can be sorted on the basis of how serious they are. High-grintraepithelial neoplasia of prostate ade suggests that there have been substantial changes. It usually takes at least five years for cancer to be manifested and sometimes evenle. When a pathologist does this finding, the doctor can discuss with the patient to determine the best procedure. This may depend on the patient's age and the general level of physical health.
One option is to recommend a number of re -tests. The doctor may continue to examine the prostate and collect biopsy samples to evaluate. It is important to carefully select new biopsy points to ensure that a good cell distribution is provided for a pathologist. This increases the chances of observing a dangerous change indicating that prostate cancer has developed.
In patients who are very old or have basic health conditions that are likely to prove fatal, treatment of high -quality intraepithelial newborn prostate may include less aggressive effect. The waiting approach and see that the patient is as healthy and stable as possible, without specific measures to solve the prostate gland. People canOU prefer this possibility to ensure that invasive re -control of the gland for cancer signs that are likely to evolve only at the end of their lives, and never have to be large enough to be fatal than the patient dies of something else.